Breast Imaging Market Size Incredible Possibilities And Growth Analysis
The Breast Imaging Market is projected to grow from an estimated USD 3.1 billion in 2018 to USD 4.6 billion by 2023, at a CAGR of 8.0%.
(EMAILWIRE.COM, August 01, 2019 ) Breast Imaging Technologies Market growth is largely driven by factors such as technological advancements, the rising prevalence of breast cancer, the increasing number of screening programs as well as rising number of conferences and symposiums focusing on spreading awareness about the benefits of early screening and diagnosis. The emerging markets, growing government and private investments to meet the increasing demand for breast cancer screening, and the improving reimbursement scenario are expected to present a wide range of growth opportunities.
The global breast imaging industry is segmented into ionizing breast imaging, non-ionizing breast imaging, and other breast imaging technologies. The non-ionizing breast imaging segment is expected to grow at the highest CAGR during the forecast period. Growth in this segment can be attributed to the advantages offered by non-ionizing breast imaging technologies over ionizing breast imaging technologies, such as greater generation of anatomical details for diagnosis, high sensitivity to small breast lesions in women with dense breast tissues, and fewer false positives.
Breast Imaging Market Growth Request Free PDF Brochure -
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=897
Non-ionizing breast imaging technologies comprise breast ultrasound, breast MRI, automated whole-breast ultrasound (AWBU), and breast thermography. The breast ultrasound segment accounted for the largest share of the non-ionizing breast imaging technologies market in 2018 whereas the AWBU segment is estimated to witness the second-highest growth rate during the forecast period. The large share of the breast ultrasound segment can be attributed to the lower risk of exposure to radiation and the benefits offered by breast ultrasound such as the ability to detect lesions and the nature of lesions in women with dense breast tissues, the ability to differentiate between a cyst and a solid mass, and the detection of blood flow through vessels.
Breast Imaging Market: Region-wise Outlook
The Asia Pacific is one of the major revenue-generating regions in the breast imaging market. China, India, and Japan are the major countries responsible for the high growth of this regional market owing to factors such as the increasing per capita income, improving healthcare infrastructure, and supportive government activities in these emerging countries focusing on the improvement of breast health. Furthermore, the increasing geriatric population and the growing incidence of breast cancer are also driving the growth of this regional market.
Breast Imaging Market: Key Players
Hologic, Inc. (US), GE Healthcare (US), Siemens Healthineers (Germany), and Philips Healthcare (Netherlands) dominated the breast imaging market. Other players in this market include Fujifilm Holdings Corporation (Japan), Aurora Imaging Technology, Inc. (US), Canon Inc. (Japan), CMR Naviscan Corporation (US), Delphinus Medical Technologies, Inc. (US), Dilon Technologies, Inc. (US), KUB Technologies Inc. (Kubtec) (US), Micrima Limited (UK), Planmed Oy (Finland), SonoCiné, Inc. (US), and SuperSonic Imagine (France), among others.
Hologic, Inc. (US) is one of the leading players in the global breast imaging market. Its broad portfolio of breast imaging products is the key factor accounting for its large share in this market. The company has adopted both organic and inorganic growth strategies such as agreements, partnerships, collaborations, product launches, and contracts to maintain its top position in the market. The company is also focused on providing training and conducting workshops to increase the adoption of its products.
Request For TOC: https://www.marketsandmarkets.com/Market-Reports/breast-imaging-technologies-market-897.html
The global breast imaging industry is segmented into ionizing breast imaging, non-ionizing breast imaging, and other breast imaging technologies. The non-ionizing breast imaging segment is expected to grow at the highest CAGR during the forecast period. Growth in this segment can be attributed to the advantages offered by non-ionizing breast imaging technologies over ionizing breast imaging technologies, such as greater generation of anatomical details for diagnosis, high sensitivity to small breast lesions in women with dense breast tissues, and fewer false positives.
Breast Imaging Market Growth Request Free PDF Brochure -
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=897
Non-ionizing breast imaging technologies comprise breast ultrasound, breast MRI, automated whole-breast ultrasound (AWBU), and breast thermography. The breast ultrasound segment accounted for the largest share of the non-ionizing breast imaging technologies market in 2018 whereas the AWBU segment is estimated to witness the second-highest growth rate during the forecast period. The large share of the breast ultrasound segment can be attributed to the lower risk of exposure to radiation and the benefits offered by breast ultrasound such as the ability to detect lesions and the nature of lesions in women with dense breast tissues, the ability to differentiate between a cyst and a solid mass, and the detection of blood flow through vessels.
Breast Imaging Market: Region-wise Outlook
The Asia Pacific is one of the major revenue-generating regions in the breast imaging market. China, India, and Japan are the major countries responsible for the high growth of this regional market owing to factors such as the increasing per capita income, improving healthcare infrastructure, and supportive government activities in these emerging countries focusing on the improvement of breast health. Furthermore, the increasing geriatric population and the growing incidence of breast cancer are also driving the growth of this regional market.
Breast Imaging Market: Key Players
Hologic, Inc. (US), GE Healthcare (US), Siemens Healthineers (Germany), and Philips Healthcare (Netherlands) dominated the breast imaging market. Other players in this market include Fujifilm Holdings Corporation (Japan), Aurora Imaging Technology, Inc. (US), Canon Inc. (Japan), CMR Naviscan Corporation (US), Delphinus Medical Technologies, Inc. (US), Dilon Technologies, Inc. (US), KUB Technologies Inc. (Kubtec) (US), Micrima Limited (UK), Planmed Oy (Finland), SonoCiné, Inc. (US), and SuperSonic Imagine (France), among others.
Hologic, Inc. (US) is one of the leading players in the global breast imaging market. Its broad portfolio of breast imaging products is the key factor accounting for its large share in this market. The company has adopted both organic and inorganic growth strategies such as agreements, partnerships, collaborations, product launches, and contracts to maintain its top position in the market. The company is also focused on providing training and conducting workshops to increase the adoption of its products.
Request For TOC: https://www.marketsandmarkets.com/Market-Reports/breast-imaging-technologies-market-897.html
Contact Information:
MarketsandMarkets™
Mr. Shelly Singh
Tel: 1-888-600-6441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
MarketsandMarkets™
Mr. Shelly Singh
Tel: 1-888-600-6441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results